Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured in The New York Times, the study opens new discussions about screening opportunities.
Article links:
Three-part series in The Lancet examines cardiovascular risk before, during and after pregnancy as a…
In general, minimally invasive surgery refers to procedures performed using small incisions with the aid…
A national TODAY feature highlights the remarkable recovery of Bensten Schone, a McLean teenager who…
Leesburg, VA – Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…
Christina Baselga, MD is a primary care physician at Inova 360° Concierge Medicine. A board-certified…
Inova Schar Heart and Vascular is continuing to build upon its legacy of innovation in…